Vahaticor, Inc.
Clinical trials sponsored by Vahaticor, Inc., explained in plain language.
-
New device aims to ease stubborn chest pain in heart disease patients
Symptom relief Recruiting nowThis early study tests a device called the A-FLUX Reducer, placed in a heart vein, to improve chest pain in 30 adults with microvascular angina (small vessel heart disease). The goal is to see if it is safe and can reduce symptoms. Participants must have had persistent chest pain…
Phase: NA • Sponsor: VahatiCor, Inc. • Aim: Symptom relief
Last updated May 17, 2026 02:54 UTC
-
New heart device aims to stop chest pain in patients with tiny vessel blockages
Symptom relief Recruiting nowThis early study tests a device called the A-FLUX Reducer, placed in a heart vein to improve blood flow and reduce chest pain in people with coronary microvascular dysfunction (small vessel disease). About 30 adults with ongoing symptoms despite standard treatments will take part…
Phase: NA • Sponsor: VahatiCor, Inc. • Aim: Symptom relief
Last updated May 15, 2026 11:57 UTC